Treatment Overview
The Korea-Specialized Next-Generation Sequencing Prenatal Panel in Korea is an advanced prenatal genetic testing platform developed to detect a wide range of fetal genetic abnormalities with high precision. This state-of-the-art diagnostic approach analyzes fetal DNA at the molecular level to identify single-gene mutations, microdeletions, duplications, and chromosomal abnormalities that may impact fetal health and development.
Korea has become one of the global leaders in genomic medicine and prenatal diagnostics, offering specialized NGS panels tailored to both Korean and international populations. These panels are designed to target genes most relevant to Asian-specific hereditary disorders as well as globally recognized genetic conditions.
With advanced sequencing facilities, AI-driven bioinformatics systems, and highly trained genetic specialists, Korea’s prenatal NGS programs provide unparalleled accuracy and reliability — ensuring early diagnosis, informed decision-making, and improved pregnancy outcomes.
Purpose & Benefits
Purpose:
- To identify genetic mutations responsible for hereditary or congenital disorders in the fetus.
- To detect rare single-gene syndromes and structural variants not visible through standard karyotyping or chromosomal microarray.
- To provide precise diagnostic information for high-risk pregnancies.
- To aid in pregnancy management, delivery planning, and postnatal care preparation.
- To guide family counseling and recurrence-risk assessment for future pregnancies.
Benefits:
- High diagnostic yield: Detects more conditions than traditional methods.
- Personalized Korean-based panels: Includes diseases prevalent in Asian populations for greater local relevance.
- Early and accurate results: Enables timely medical decisions and early interventions.
- Comprehensive genetic insight: Analyzes hundreds of genes associated with fetal and neonatal disorders.
- Non-invasive or minimally invasive sample options: Can be performed on maternal blood or amniotic fluid samples.
- Integrated clinical approach: Combines genetic, obstetric, and perinatal expertise.
Ideal Candidates
The NGS Prenatal Panel is especially recommended for:
- High-risk pregnancies identified by abnormal ultrasound or screening results.
- Couples with a family history of genetic or metabolic disorders.
- Parents carrying known gene mutations or chromosomal abnormalities.
- Pregnancies showing unexplained structural anomalies or growth abnormalities.
- Recurrent miscarriage cases or previous pregnancies with genetic syndromes.
- IVF or ART patients seeking preimplantation or prenatal confirmation testing.
- Advanced maternal age pregnancies (35 years and older).
Possible Risks & Considerations
- The test itself is safe and low-risk, requiring only a small DNA sample (maternal blood or fetal fluid).
- Invasive sampling (amniocentesis or CVS) may be necessary in some cases for diagnostic confirmation, carrying a small procedural risk.
- Variants of uncertain significance (VUS): Some detected mutations may have unclear implications, requiring expert interpretation.
- Emotional impact: Learning complex genetic information may cause temporary stress; counseling support is essential.
- Korean hospitals provide thorough pre- and post-test counseling, ensuring clarity and emotional comfort throughout the process.
Medical & Diagnostic Techniques Used in Korea
Korean hospitals utilize world-class sequencing technologies and bioinformatics pipelines to deliver reliable, high-resolution genetic data from minimal fetal DNA samples.
Key Diagnostic Technologies Include:
- Next-Generation Sequencing (NGS): High-throughput technology analyzing millions of DNA fragments simultaneously.
- Targeted Gene Panels: Korean-specific panels designed to detect disorders common in Asian and global populations.
- Whole-Exome Sequencing (WES): Analyzes all protein-coding regions for rare or novel mutations.
- Copy Number Variation (CNV) Analysis: Detects microdeletions and duplications not visible in karyotyping.
- Mitochondrial DNA Testing: Identifies metabolic and neurodevelopmental disorders caused by mtDNA mutations.
- AI-Assisted Variant Classification: Automated interpretation of genetic variants based on global and Korean genomic databases.
- Trio Sequencing (Fetus + Parents): Enhances accuracy by comparing genetic information across family members.
- Integrated Phenotype-Genotype Correlation: Combines ultrasound findings with molecular data for precision diagnosis.
Korean laboratories are globally recognized for their precision, speed, and innovative sequencing algorithms tailored for prenatal medicine.
Recovery & Aftercare
- No physical recovery required: The sequencing process itself is laboratory-based.
- Minimal observation period: For patients undergoing amniocentesis or CVS, a short recovery period is advised.
- Results timeline: Reports are usually available within 2 to 4 weeks, depending on test complexity.
- Follow-up care: Genetic counseling sessions are provided to explain results, implications, and recommended actions.
- Continued monitoring: Obstetricians coordinate further prenatal assessments if any genetic risk is detected.
- Emotional support: Specialized counseling services help families process results and make informed choices.
Results & Longevity
- Comprehensive genetic diagnosis: Detects mutations responsible for thousands of possible conditions.
- High clinical utility: Provides actionable results that influence pregnancy and neonatal management.
- Lifetime relevance: Genetic findings remain valid for future pregnancies and family planning.
- Enhanced predictive care: Early insights allow for timely intervention and improved outcomes.
- Supports precision medicine: Results contribute to long-term maternal and child healthcare strategies.
Korean hospitals emphasize clarity, empathy, and medical accuracy in reporting, ensuring families fully understand their results and options.
Procedure Process in Korea
1. Pre-Test Consultation
A genetic counselor or maternal-fetal specialist reviews family medical history, pregnancy background, and prior screening results. The counselor explains the NGS panel’s purpose, process, and potential findings.
2. Sample Collection
Depending on gestational stage and indication, fetal DNA is obtained through:
- Maternal blood draw (for non-invasive cfDNA-based analysis) or
- Amniocentesis/CVS (for direct fetal genetic material).
3. Laboratory Sequencing & Bioinformatics Analysis
DNA is extracted, sequenced using next-generation platforms, and analyzed using AI-driven bioinformatics pipelines. Korean-specific panels include optimized genomic data from local populations for enhanced accuracy.
4. Interpretation & Reporting
Results are reviewed by a multidisciplinary team including geneticists, obstetricians, and pediatric specialists. Variants are categorized (pathogenic, likely pathogenic, benign, or VUS) following international standards.
5. Genetic Counseling & Management
The findings are explained in detail to the parents, along with management recommendations, delivery planning, or neonatal care guidance if abnormalities are detected.
Why Korea Is a Top Destination
- Pioneering NGS technology: Korean hospitals lead Asia in prenatal sequencing innovation.
- Comprehensive high-risk pregnancy programs: Integrate genetics, ultrasound, and maternal care.
- AI-powered genomic interpretation systems for unmatched accuracy.
- Collaboration between genetics, obstetrics, and neonatology for holistic prenatal care.
- Internationally accredited laboratories adhering to global genomic quality standards.
Unique Korean Methods & Technology
- Korea-specific genetic panels: Include population-relevant genes for precise regional diagnostics.
- AI-enhanced sequencing interpretation: Speeds up analysis and improves variant classification.
- Hybrid WES–panel testing: Combines broad exome coverage with focused pathogenic variant analysis.
- Real-time cloud-integrated reporting systems: Ensure quick and secure access to results.
- Multidisciplinary care coordination: Korean hospitals seamlessly connect testing, counseling, and treatment.
Cost Range
The cost of Korea-Specialized Next-Generation Sequencing Prenatal Panel depends on test scope, hospital, and level of analysis:
- Targeted NGS panel (100–300 genes): USD 1,200 – 2,000
- Whole-exome sequencing (fetus only): USD 1,800 – 2,800
- Trio-based NGS analysis (fetus + parents): USD 2,500 – 4,000
- Comprehensive prenatal NGS package (includes counseling and ultrasound correlation): USD 3,000 – 5,000
Many hospitals in Korea offer bundled prenatal genetics programs combining NGS panels with maternal-fetal imaging, counseling, and risk profiling for complete high-risk pregnancy care.
Popular Hospitals and Centers in Korea
- Asan Medical Center (Seoul): A leader in prenatal NGS diagnostics and genomic medicine.
- Samsung Medical Center (Seoul): Offers AI-integrated prenatal NGS analysis and genetic counseling.
- Severance Hospital (Yonsei University Health System): Provides comprehensive fetal exome sequencing services.
- CHA Bundang Women’s Hospital: Specializes in NGS panels tailored to IVF and high-risk pregnancies.
- MizMedi Women’s Hospital: Focuses on accessible prenatal NGS testing and multidisciplinary pregnancy care.
